Patents by Inventor Matthew John During

Matthew John During has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230332176
    Abstract: The present invention relates to gene therapy for treatment or prevention of choroideremia.
    Type: Application
    Filed: October 26, 2022
    Publication date: October 19, 2023
    Inventors: Robert E. Maclaren, Miguel Seabra, Matthew John During
  • Publication number: 20210032656
    Abstract: The present invention relates to gene therapy for treatment or prevention of choroideremia.
    Type: Application
    Filed: January 24, 2020
    Publication date: February 4, 2021
    Inventors: Robert Maclaren, Miguel Seabra, Matthew John During
  • Publication number: 20180135078
    Abstract: The present invention relates to gene therapy for treatment or prevention of choroideremia.
    Type: Application
    Filed: October 31, 2017
    Publication date: May 17, 2018
    Inventors: Robert MACLAREN, Miguel SEABRA, Matthew John DURING
  • Patent number: 9834788
    Abstract: The present invention relates to gene therapy for treatment or prevention of choroideremia.
    Type: Grant
    Filed: February 21, 2012
    Date of Patent: December 5, 2017
    Assignee: Oxford University Innovation Limited
    Inventors: Robert Maclaren, Miguel Seabra, Matthew John During
  • Publication number: 20140107185
    Abstract: The present invention relates to gene therapy for treatment or prevention of choroideremia.
    Type: Application
    Filed: February 21, 2012
    Publication date: April 17, 2014
    Applicant: ISIS INNOVATION LIMITED
    Inventors: Robert Maclaren, Miguel Seabra, Matthew John During